Epizyme Inc Share Price (NASDAQ: EPZM)
Last updated on
This instrument is not available for trading on the INDmoney app on 11 Aug 2022
Check the interactive Epizyme Inc Stock chart to analyse performance
Analyst Recommendation on Epizyme Inc Stock
Buy
66%Buy
33%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Epizyme Inc(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
About Epizyme Inc
Important FAQs about investing in EPZM Stock from India :
What is Epizyme Inc share price today?
Epizyme Inc share price today is as on at the close of the market. Epizyme Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Epizyme Inc share?
Epizyme Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Epizyme Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.
How to invest in Epizyme Inc Stock (EPZM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Epizyme Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Epizyme Inc Shares .
What is the minimum amount required to buy Epizyme Inc Stock (EPZM) from India?
Indian investors can start investing in Epizyme Inc (EPZM) shares with as little as ₹93.96 or $1 (as of March 26, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹939.60 in Epizyme Inc stock (as per the Rupee-Dollar exchange rate as on March 26, 2026).
Learn more about
fractional shares .
What are the returns that Epizyme Inc has given to Indian investors in the last 5 years?
Epizyme Inc stock has given 0.0% share price returns and 29.3% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
First Trust Capital Strength$93.14
+0.6%
Lemonade Inc$67.09
+2.47%
Central Garden & Pet Co$37.51
+1.16%
Beta Technologies$15.36
+4.49%
Prelude Therapeutics Inc$3.27
+4.81%
Dimensional Us Core Equity M$45.52
+0.55%
Kairos Pharma Ltd.$0.60
-4.76%
Wisdomtree International Equity Fund$69.86
+1.63%
Aios Tech Inc$0.59
+5.36%